key: cord-0778023-onbfqohj
authors: Hoque, M. Nazmul; Rahman, M. Shaminur; Ahmed, Rasel; Hossain, Md. Sabbir; Islam, Md. Shahidul; Islam, Tofazzal; Hossain, M. Anwar; Siddiki, A.M.A.M. Zonaed
title: Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases
date: 2021-05-07
journal: Gene Rep
DOI: 10.1016/j.genrep.2021.101200
sha: f0470863e5b570ac269e60604ecf139df668f1b1
doc_id: 778023
cord_uid: onbfqohj

The novel coronavirus disease 2019 (COVID-19) is a rapidly emerging and highly transmissible disease caused by the Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2). Understanding the microbiomes associated with the upper respiratory tract infection (URTI), chronic obstructive pulmonary disease (COPD) and COVID-19 diseases has clinical interest. We hypothesized that the diversity of microbiome compositions and their genomic features are associated with different pathological conditions of these human respiratory tract diseases (COVID-19 and non-COVID; URTI and COPD). To test this hypothesis, we analyzed 21 whole metagenome sequences (WMS) including eleven COVID-19 (BD = 6 and China = 5), six COPD (UK = 6) and four URTI (USA = 4) samples to unravel the diversity of microbiomes, their genomic features and relevant metabolic functions. The WMS data mapped to 534 bacterial, 60 archaeal and 61 viral genomes with distinct variation in the microbiome composition across the samples (COVID-19>COPD>URTI). Notably, 94.57%, 80.0% and 24.59% bacterial, archaeal and viral genera shared between the COVID-19 and non-COVID samples, respectively, however, the COVID-19 related samples had sole association with 16 viral genera other than SARS-CoV-2. Strain-level virome profiling revealed 660 and 729 strains in COVID-19 and non-COVID sequence data, respectively and of them 34.50% strains shared between the conditions. Functional annotation of metagenomics sequences of thevCOVID-19 and non-COVID groups identified the association of several biochemical pathways related to basic metabolism (amino acid and energy), ABC transporters, membrane transport, replication and repair, clustering-based subsystems, virulence, disease and defense, adhesion, regulation of virulence, programmed cell death, and primary immunodeficiency. We also detected 30 functional gene groups/classes associated with resistance to antibiotics and toxic compounds (RATC) in both COVID-19 and non-COVID microbiomes. Furthermore, a predominant higher abundance of cobalt-zinc-cadmium resistance (CZCR) and multidrug resistance to efflux pumps (MREP) genes were detected in COVID-19 metagenome. The profiles of microbiome diversity and associated microbial genomic features found in both COVID-19 and non-COVID (COPD and URTI) samples might be helpful for developing the microbiome-based diagnostics and therapeutics for COVID-19 and non-COVID respiratory diseases. However, future studies might be carried out to explore the microbiome dynamics and the cross-talk between host and microbiomes employing larger volume of samples from different ethnic groups and geoclimatic conditions.

The nasopharyngeal specimens were collected from patients presenting with potential COVID-19 infections following the guidance of the Director General of Health Services of Bangladesh. A single dry swab was inserted through one nostril straight back (NOT upwards), along the floor of the nasal passage up to the posterior wall of the nasopharynx, and rubbed against and above the nasal turbinate. The swab was rotated a few times against the nasal wall before removing. A second swab was used to abrade the tonsils and pharynx. The swabs were placed in sample collection vial containing normal saline, and preserved at -20 °C until further use for RNA extraction. The confirmatory diagnosis of SARS-CoV-2 infections were made by RT-qPCR (Péré et al., 2020) .

We further intended to characterize the microbial community present along with the SARS-CoV-2 virus in the nasopharyngeal specimens of COVID-19 patients through whole metagenome sequencing (WMS). We utilized total RNA-Seq approach for metagenomics study, and total RNA was extracted from five (n=5) COVID-19 positive patients using TRIzol (Invitrogen) reagent following manufacturer's protocol. RNA-Seq libraries were prepared from isolated total RNA using TruSeq Stranded Total RNA Library Prep kit (Illumina) according to the manufacturer's instructions where first strand cDNA was synthesized using SuperScript II Reverse Transcriptase (Thermo Fisher), and random primers (Visnovska et al., 2019; Zhou et al., 2020) . Paired-end (2 x 150 bp reads) sequencing of the RNA library was performed on the J o u r n a l P r e -p r o o f Illumina NextSeq 500 platform. RNA extraction, library preparation, and sequencing were carried out at the Basic and Applied Research on Jute Project, Dhaka, Bangladesh.

In addition to our five COVID-19 metagenome sequences, we retrieved six (n=6) Chinese COVID-19 metagenome sequences from the NCBI (National Center for Biotechnology Information) database (https://www.ncbi.nlm.nih.gov/) (Accession numbers: SRX7705831-SRX7705836), four (n=4) shotgun metagenome sequences of human URTI belonged to CDC, USA from the NCBI (Accession numbers: SRR10252885, SRR10252888, SRR10252889 and SRR10252892 under bio-project: PRJNA573045), and six (n=6) metagenome sequences of human COPD from the European Nucleotide Archive, UK (Accession numbers: ERR2732537, ERR2732541, ERR2732559, ERR2732558, ERR2732551 and ERR2732550 under bio-project: PRJEB14074). Therefore, the current metagenome study included 21 sequences including 11 COVID-19 (BD=5, China=6) and 10 non-COVID (USA=4, UK=6) sequences to investigate the microbiome diversity and composition, and metabolic functional potentials associated with COVID 19 (BD and China), and non-COVID respiratory diseases (COPD; UK and URTI; USA).

The shotgun WMS data were analyzed using the assembly-based hybrid method MG-RAST (release version 4.1) (Glass et al., 2010) . The paired-end FASTQ files were concatenated and filtered through BBDuk (Stewart et al., 2018) (with options k = 21, mink = 6, ktrim = r, ftm = 5, qtrim = rl, trimq = 20, minlen = 30, overwrite = true) to remove Illumina adapters, known Illumina artifacts, and phiX. Any sequence below these thresholds or reads containing more than one 'N' were discarded. In the current study, 46.04 million reads in two metagenomes with an average of 2.19 million reads per sample passed the quality control steps (Supplementary Data 1). The trimmed sequences were uploaded to the MG-RAST server with properly embedded metadata and were subjected to optional quality filtering with dereplication and host DNA removal, and finally screening for taxonomic and functional assignment. Alpha diversity (diversity within samples) was estimated using the observed species, and Shannon diversity indices (Koh, 2018) MG-RAST read assignments and counts. To visualize differences in bacterial diversity, principal coordinate analysis (PCoA; at genus level) based on the Bray-Curtis distance method (Beck et al., 2013) . Taxonomic abundance was determined by applying the ''Best Hit Classification'' option using the NCBI database as a reference with the following settings: maximum e-value of 1x10 -30 ; minimum identity of 80% for bacteria, 60% for archaea and viruses, and a minimum alignment length of 20 as the set parameters. A 'target' genome library was constructed containing all viral sequences from the NCBI RefSeq Release 201 database (https://en.wikipedia.org/wiki/National_Center_for_Biotechnology_Information) using the Kraken 2 (Wood et al., 2019) , and the metagenomics reads were then aligned against the target library using the BWA algorithm (Jaillard et al., 2016) . Finally, the PathoScope 2 was used for strain level taxonomic assignment of the viruses (Hong et al., 2014) . In all of the bioinformatics analysis, the Chinese sequences were used only as forward sequences.

The non-parametric test Kruskal-Wallis rank sum test was used to evaluate differences in the relative percent abundance of taxa in COVID-19 and non-COVID (URTI and COPD) sequence data. Comparative taxonomic and functional profiling was performed with the reference prokaryotic metagenomes available in MG-RAST database for statistical analyses. The gene counts were normalized by dividing the number of gene hits to individual taxa/function by total number of gene hits in each metagenome to remove bias due to differences in sequencing efforts. To identify differentially abundant SEED or KEGG functions, and resistance to antibiotics and toxic compounds (RATCs) across the four sampling locations (BD, China, UK and USA), statistical tests were applied with non-parametric test Kruskal-Wallis rank sum test at different KEGG and SEED subsystems levels IBM SPSS (SPSS, Version 23.0, IBM Corp., NY, USA).

The COVID-19 disease significantly affected the diversity (Shannon estimated alpha diversity, P=0.036, Kruskal-Wallis test) and composition (Bray-Curtis distance estimated beta diversity, P=0.021, Kruskal-Wallis test) of respiratory tract microbiome (Fig. 1) . The rarefaction curves showed that sequencing depth was sufficient to capture the entire microbial diversity among the samples of the study (Fig. S1 ). Both the number of identified microbial taxa and Shannon estimated alpha diversity were significantly higher in COVID-19 samples (BD and China) than the non-COVID (UK and USA) samples (Fig. 1A) . The principal coordinate analysis based on Bray-Curtis distances showed distinct separations among the four sampling locations (Bangladesh, China, USA, and UK) (Fig. 1B) . Notably, the COVID-19 related samples (BD and China) remained more similar than the URTI and COPD-associated samples from the USA and J o u r n a l P r e -p r o o f UK (Fig. 1B) . Moreover, across the non-COVID respiratory diseases (URTI and COPD)associated samples of UK and USA, all of the samples clustered more closely than those of COVID-19 samples (BD and China) indicating that SARS-CoV-2 infections are associated with diverse secondary microbial communities (Fig. 1B) .

The composition of COVID-19 (BD and China) and non-COVID respiratory disease (URTI; USA and COPD; UK)-related microbiomes at the domain level was dominated by bacteria, with a relative abundance of >99.50, followed by archaea (~ 0.3%), and viruses (~0.2%) (Data S1). Twenty-eight bacterial phyla were identified in COVID-19 (BD and China), and non-COVID (UK and USA) metagenomes including 28, 10, 28 and 27 phyla in BD, China, UK and USA samples, respectively (Data S1). A total of 534 bacterial genera were detected across the four sample locations including 527, 306, 512 and 443 in BD, China, UK and USA samples, respectively ( Fig. 2A , Data S1). About 95% (505/534) of the detected bacterial genera shared in both COVID-19 and non-COVID diseases, and only 22 genera had unique association with COVID-19 disease ( Fig. 2 A, Data S1). In addition to bacteria, 60 archaeal and 61 viral genera were detected, and of them 48, 10, 60 and 31 archaeal genera (Fig. S2B ), and 31, 5, 36 and 18 viral genera ( Fig. S2C ) were identified in BD, China, UK and USA, respectively. Of the detected archaeal genera, majority of the genera (80.0%) were found to be shared in both sample groups, and only 20.0% (12/60) archaeal genera had unique association with non-COVID diseases (Fig. 2B , Data S1). Similarly, 26.23% and 49.18% of the detected viral genera had unique association with COVID-19 and non-COVID diseases, respectively, and 24.59% genera were found to be shared between the conditions (Fig. 2C , Data S1). The strain level profiling of the viral communities revealed 1032 strains including 660 and 729 in the COVID-19 and non-COVID samples, respectively ( Fig. 2 D , Data S1). Of the identified strains, 303 in COVID-19

The viral fraction of the microbiome was largely dominated by Betacoronavirus (99.67% of the total abundance) genus in the COVID-19 related samples (BD; 99.55% and China; 99.98%) while the relative abundance of this genus was 39.78% in the non-COVID samples. In addition, Siphovirus (33.17%), Alphapapillomavirus (12.01%) and Myovirus (7.16%) were the most predominant viral genera in non-COVID samples (Fig. 6 , Data S1). Rest of the viral genera detected across the both sample groups had lower relative abundances (<1.0%) (Data S1). The varied. The COVID-19 related microbiomes had relatively higher abundance of genes encoding for pathogenicity islands (21.55%; BD=18.69% and China=24.42%), clustering-based subsystems (21.15%; BD=22.23% and China=20.07%), regulation of virulence (20.34%; BD=24.41% and China=16.28%), biofilm adhesion biosynthesis (18.49%; BD=11.58% and China=25.40), adhesion (17.96%; BD=16.77% and China=19.13%), programmed cell death (13.53%; BD=14.85% and China=12.21%), membrane transport (6.66%; BD=7.83% and China=8.50%), gene transfer agent (5.00%; BD=5.88% and China=4.12%) and virulence, disease and defense (3.39%; BD=3.78% and China=3.00%) (Fig. 8B , Data S2). In contrast, genes coding for oxidative stress (48.75%; UK=41.89%, USA=65.60%), periplasmic stress (6.49%; UK=10.40%, USA=2.56), cell division (4.65%; UK=3.29%, USA=6.01%), invasion and intracellular resistance (2.88%; UK=1.70%, USA=4.06%), and phages, prophages and transposable elements (1.26%; UK=1.40%, USA=1.11%) were upregulated in the non-COVID related COPD and URTI causing microbiomes (Fig. 8B , Data S2).

The resistome analysis of the COVID-19 (BD and China) and non-COVID (UK and USA)-associated microbiomes, the SEED module of the MG-RAST pipeline provided a comprehensive scenario. Using SEED, 150,146 reads mapped to 30 resistance to antibiotics and toxic compounds (RATC) functional groups across the sample across the four geographic regions, with different relative abundances (Data S2). The RATC genes were classified into two unique groups such as antibiotic resistance (n=17) and toxic metal resistance (n=13) group.

Among the RATC functional groups, cobalt-zinc-cadmium resistance (CZCR) had higher relative abundances in COVID-19 microbiomes (23.69%; BD=25.85%, China=21.53%) J o u r n a l P r e -p r o o f Journal Pre-proof compared to non-COVID (10.34%; UK=11.75%, USA=8.92%) microbiomes (Fig. 9 , Data S2). Moreover, the RATC functional genes associated with beta lactamase (BLAC) (13.55%; BD=9.23% and China=17.87%), copper homeostasis (CH) (11.18%; BD=12.33% and China=10.02%), multidrug resistance to efflux pumps (MREP) (10.97%; BD=14.75% and China=7.19%), multidrug resistance cluster (mdtABCD) (5.34%; BD=4.57% and China=6.11%), arsenic resistance (AR) (4.76%; BD=6.27% and China=3.26%) and multidrug-efflux-pump in Campylobacter jejuni (CmeABC) operon (1.86%; BD=2.74% and China=0.98%) had higher relative abundances in the COVID-19 associated microbiomes than the non-COVID respiratory disease (COPD and URTI) causing microbiomes ( Fig. 9 ; Data S2). Conversely, gens coding for resistance to fluoroquinolones (RFL) (22.31%; UK=26.16%, USA=18.46%), BlaR1-Family-Regulatory-Sensor-Transducer-Disambiguation (BlaR1) family (15.47%; UK=9.71% and USA=21.23%), methicillin resistance in Staphylococci (MRS) (8.20%; UK=10.55% and USA=5.85%), resistance to chromium compounds (RCHC) (5.11%; UK=1.05%, USA=9.23%), Streptococcus pneumonia-vancomycin-tolerance-locus (SPVANT) (3.39%; UK=3.71%, USA=3.07%), mercury resistance to operon (MRO) (2.34%; UK=2.53% and USA=2.15%) and copper homeostasis: copper tolerance (CHCT) (2.07%; UK=2.91%, USA=1.23%) were found to be over expressed in the COPD and URTI-associated non-COVID microbiomes (Fig. 9 , Data S2). Rest of the RATC genes detected in both metagenomes also varied in their relative abundances.

The present study represents a proof-of-concept to decipher changes in microbiome compositions and diversity in COVID-19 (BD and China), and non-COVID related chronic obstructive pulmonary disease; COPD (UK), and upper respiratory tract infection; URTI (USA).

Several recent studies showed that COVID-19 is associated with dysbiosis of the gut microbiomes (Dhar and Mohanty, 2020; Zuo et al., 2020) . Respiratory tract especially lung microbiome is more dynamic and transient than that of the gastrointestinal tract because of bidirectional movement of air and mucus (Huffnagle et al., 2017) . This makes it plausible that SARS-CoV-2 infections could lead to abnormal inflammatory reactions to worsen the symptoms of COVID-19. The microbiome diversity (alpha and beta diversity) measures revealed higher microbial diversity in COVID-19 samples which remained more similar than the URTI and COPD-associated samples from the USA and UK. Regardless of higher taxonomic abundances, the COVID-19-associated microbiomes remained inconsistent and fluctuates more within BD and China metagenomes than those of UK and USA samples. In a recent study, Zou et al. (2020) reported that loss of salutary species in COVID-19 persisted in most patients despite clearance of SARS-CoV-2 virus, and is associated with a more long-lasting detrimental effect to the gut microbiome.

In the present study, although the dominant microbial phyla showed no significant difference between two groups, COVID-19 still affected the prevalence of some microbes belonging to Proteobacteria and Cyanobacteria corroborating the recent findings of Khatiwada and Subedi (2020) . To be specifically, in COVID-19 samples of BD and China, the abundance of Proteobacteria, Tenericutes, and Cyanobacteria were significantly higher. Conversely, (Man et al., 2017) inflammations. The upper respiratory tract is generally considered to be a major reservoir for potential pathogens, including Streptococcus, Veillonella, Pseudomonas, Clostridium, Rothia, and Neisseria, to expand and subsequently spread towards the lungs, which could potentially lead to a chronic infection like COPD (Man et al., 2017; Ditz et al., 2020) . The findings of the present study suggested that bacteriome composition in COVID-19 and non-COVID associated COPD and URTI might be similar at phylum level, however, could vary significantly at genus and strain levels which might be related to the age, gender, weight, food habit, and different living environment (Wang et al., 2018) .

Thus, establishing and maintaining a balanced microbiota in the COVID-19 and non-COVID respiratory disease (URTI and COPD) samples that is resilient to pathogenic expansion and invasion could prove vital for respiratory health. Moreover, 94.57% bacterial genera including . Methanogenic archaea utilize low molecular weight compounds, such as H2 + CO2, formic acid, or acetate, and therefore have symbiotic relationships with the producers of these substrates. Therefore, it is reasonable to hypothesize that the presence or increase in level of methanogenic archaea alters the composition of the polymicrobial community thus resulting in changes in virulence of the flora (Maeda et al., 2013; Hoque et al., 2020b) . The viral fraction of the microbiome was largely dominated by Betacoronavirus genus in the COVID-19 related samples of BD and China. Conversely, the virome fraction of the non-COVID (URTI and COPD) sasmples were mostly represented by the genera belonged to the order Caudovirales which consists of the three families of tailed bacterial viruses (bacteriophages) infecting bacteria and archaea (Hoque et al., 2019; Hoque et al., 2020b) .

The host range of Caudovirales is very broad and includes all major bacterial phyla found in our samples: Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria. This corresponded with an increased relative abundance of these bacterial taxa in COPD and URTI metagenomes. (Huddleston, 2014; Hoque et al., 2019; Zheng et al., 2019) . Recent scientific researches provide evidence that bacteriophages are overlooked human pathogens, implied in the triggering, and worsening of a number of human diseases (Zheng et al., 2019) . The COVID-19 causing SARS-CoV-2 strain showed neighboring relationship to human classic coronavirus, the SARS Coronavirus isolate Tor2 (SARS-CoV Tor2) corroborating with the recent findings of Hou (2020) and Konno et al. (2020) (Hou, 2020; Konno et al., 2020) . However, our current findings demonstrated that archaea and viruses (other than SARS-CoV-2) neither cause COPD and URTI directly nor play a role in the initiation of the disease process, but later, when bacterial infection of the respiratory tract occurs, they replicate in the immune and epithelial cells, and may act as a predisposing factor as well as a primary etiological agent for more severe URTI, and prolonged disease like COPD.

The functional metabolome analyses provided a promising opportunity for studying microbialhost interactions, and has uncovered significant differences in microbial metabolic functions in COVID-19 (BD and China) and non-COVID (COPD; UK and URTI; USA) samples. In this study, the COVID-19 associated microbiomes harbored relatively higher abundance of genes coding for metabolism (amino acid and energy), ABC transporters, membrane transport, replication and repair, clustering-based subsystems, virulence, disease and defense, adhesion, J o u r n a l P r e -p r o o f regulation of virulence, programmed cell death, and primary immunodeficiency diseases compared to non-COVID microbiomes. However, the specific role these metabolic pathways in the pathophysiology of the COVID-19 disease is not clearly explored still now. The metabolic activities related to virulence and immunosuppression have profound impact on SARS-CoV-2 infections as evidenced earlier from the SARS and MERS outbreaks (Thng et al., 2020) . Most recently, investigators comprehensively queried the impact of the microbiome on the metabolome throughout the body, and found that that the microbiota affected the metabolomics of every organ Lee-Sarwar et al., 2020; Quinn et al., 2020) . The observed increased abundance of genes for primary immune diseases (e.g., adenosine deaminase) in COVID-19 and COPD pathogens is responsible for inhibition of T cell maturation and lymphocytic proliferation, very low CD4 count, cell-to-cell communication and therefore could be used as a selective marker for COVID-19 and COPD diagnosis (Hoque et al., 2019) . We identified several genes as being differentially expressed in COVID-19 microbiomes that were involved in bacterial physiology, such as the bacterial secretion system by which pathogenic bacteria to secrete virulence factors for host invasion (Depluverez et al., 2016) . ABC transporters, which contribute to substrate transport across the bacterial membrane and are related to antibiotic resistance (Wilson, 2016; Zhang et al., 2020) , were also enriched with differentially expressed genes in the in COVID-19 microbiomes.

The abundance and diversity of the antibiotic and toxic compounds (RATC) genes in the human respiratory microbiome remain poorly characterized. The microbiomes (especially bacterial community) within this potential reservoir are becoming more resistant. In the context of SARS-CoV-2 virus infection, interactions between the virus, the host, and resident bacteria with pathogenic potential are known to complicate and worsen disease, resulting in coinfection Venn diagram comparison of unique and shared archaeal genera where 48 (highlighted in yellow) genera shared between the condition, and 12 genera had unique association with non-COVID URTI and COPD) diseases. (C) Venn diagrams representing unique and shared viral genera identified in both metagenomes. Of the detected viral genera (n=61), 16 and 30 genera had unique association with COVID-19 and non-COVID diseases, respectively, and 15 genera (highlighted in yellow) were found to be shared between the study metagenomes. (D) Venn diagrams showing the unique and shared viral strains in COVID-19 and Non-COVID diseases. Out of viral strains detected, 356 strains (highlighted in yellow) shared between the condition while 303 and 373 strains had unique associations with COVID-19 and Non-COVID metagenomes, respectively. More information on the taxonomic results are available in Data S1. disease, and the last two bar plots depict overall relative abundance of phyla in COVID-19 and non-COVID metagenomes, respectively. The distribution and relative abundance of the bacterial phyla in the study metagenomes are also available in Data S1.

J o u r n a l P r e -p r o o f genera, with ranks ordered from bottom to top by their increasing proportion. The first four bar plots represent the abundance of bacteria in the corresponding category of COVID-19 (BD and China) and non-COVID (URTI; USA and COPD; UK) disease, and the last two bar plots depict overall relative abundance of bacterial genera in COVID-19 and non-COVID metagenomes, respectively. Only the 33 most abundant genera are shown in the legend, with the remaining genera grouped as 'Other genera'. The distribution and relative abundance of the bacterial genera in the study metagenomes are also available in Data S1. proportion. The first four bar plots represent the abundance of archaea in the corresponding category of COVID-19 (BD and China) and non-COVID (URTI; USA and COPD; UK) disease, and the last two bar plots depict overall relative abundance of archaeal genera in COVID-19 and non-COVID metagenomes, respectively. Only the 29 most abundant genera are shown in the legend, with the remaining genera grouped as 'Other genera'. The distribution and relative abundance of the archaeal genera in the study metagenomes are also available in Data S1. Fig. 6 . The taxonomic profile virus in in COVID-19 (BD and China) and respiratory tract disease (UK and USA) metagenomes. Stacked bar plots showing the relative abundance and distribution of the 20 viral genera, with ranks ordered from bottom to top by their increasing proportion among the BD, China, UK and USA metagenomes. The first four bar plots represent the abundance of viruses in the corresponding category of COVID-19 (BD and China) and non-COVID (URTI; USA and COPD; UK) disease, and the last two bar plots depict overall relative abundance of viral genera in COVID-19 and non-COVID metagenomes, respectively. Only the 19 most abundant genera are shown in the legend, with the remaining genera grouped as 'Other genera'. The distribution and relative abundance of the viral genera in the study metagenomes are also available in Data S1. 

RND multidrug efflux pumps: what are they good for? Frontiers in microbiology 4

Undersampling and the measurement of beta diversity

Environmental factors influencing the development and spread of antibiotic resistance

Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness

Emerging coronaviruses: genome structure, replication, and pathogenesis

Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease

Insights Into the Resistome of Bovine Clinical Mastitis Microbiome, a Key Factor in Disease Complication

Metagenomic deep sequencing reveals association of microbiome signature with functional biases in bovine mastitis

Microbiome dynamics and genomic determinants of bovine mastitis

Characterization of codon usage pattern in SARS-CoV-2

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes. Infection and drug resistance 7

The respiratory tract microbiome and lung inflammation: a two-way street

Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity

Optimization of alignmentbased methods for taxonomic binning of metagenomics reads

New approach for understanding genome variations in KEGG

Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications

An adaptive microbiome α-diversity-based association analysis method

SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant

First insights into the diverse human archaeome: specific detection of archaea in the gastrointestinal tract

The microbiome of the upper respiratory tract in health and disease

Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins

Metabolome-Microbiome Crosstalk and Human Disease

Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety

Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)

Medical microbiological approach to Archaea in oral infectious diseases

The microbiota of the respiratory tract: gatekeeper to respiratory health

Pathogenesis of COVID-19 from a cell biology perspective

Paradigms of lung microbiota functions in health and disease, particularly, in asthma

Coronavirus infections-more than just the common cold

Nasal swab sampling for SARS-CoV-2: a convenient alternative in times of nasopharyngeal swab shortage

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. The Lancet infectious diseases

Global chemical effects of the microbiome include new bile-acid conjugations

Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a fast and accurate pipeline

Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach

Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein (N protein) and its consequences

Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients

The development of lower respiratory tract microbiome in mice

Assembly of 913 microbial genomes from metagenomic sequencing of the cow rumen

Time-course of upper respiratory tract viral infection and COPD exacerbation

COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs

Metagenomics and transcriptomics data from human colorectal cancer

Identification of a pangolin niche for a 2019-nCoV-like coronavirus through an extensive meta-metagenomic search

Microbiota composition in upper respiratory tracts of healthy children in Shenzhen, China, differed with respiratory sites and ages

The ABC of ribosome-related antibiotic resistance

Improved metagenomic analysis with Kraken 2

The influence of the microbiome on respiratory health

Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis

Characterization of antibiotic resistance and host-microbiome interactions in the human upper respiratory tract during influenza infection

Mining, analyzing, and integrating viral signals from metagenomic data

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Alterations in Gut Microbiota of patients with COVID-19 during time of hospitalization

We are thankful to those who deposited and shred their sequences to the GISAID, NCBI and ENA, and make open for the global research community.

Supplementary information supporting the findings of the study are available in this article as Data S1 and S2, and Figure S1 .